April 24, 2018
1616 Rhode Island Ave. NW
Washington, DC 20036
Guest Speaker: Katherine B. Szarama, Ph.D., Lead Analyst, Decision Memo for Next Generation Sequencing for Medicare Beneficiaries with Advanced Cancer, Centers for Medicare and Medicaid Services
Registration (Members Only): https://pmc.ps.membersuite.com/events/ViewEvent.aspx?contextID=16d5e16b-0078-c8f2-7fd4-0b3e18a07bb4
Katherine B. Szarama, Ph.D., the lead analyst for the U.S. Centers for Medicare and Medicaid Services (CMS)' Decision Memo for Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer, will join us at PMC's next policy committee meeting on April 24 to discuss the agency's recent decision to expand access to a subset of NGS tests approved by the U.S. Food and Drug Administration (FDA) for use in advanced cancer. Dr. Szarama will deliver remarks and take questions from the audience.
During the business portion of the meeting, which will follow our conversation with Dr. Szarama, we will examine PMC's policy priorities, including appropriations to the U.S. National Institutes of Health and FDA; the Coalition's expanding list of working groups engaging patients, industry and providers; and a landscape analysis on the integration of personalized medicine into U.S. health systems.
Please contact Christopher Wells, Vice President, Public Affairs, Personalized Medicine Coalition, at email@example.com for more information about PMC's member-only Policy Committee meetings.